Clinical Trial Update: A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys [Phase 2, Phase 3]

View source ↗

Summary

A pilot study comparing everolimus to other medicines in kidney transplant recipients with delayed graft function was terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Matthew Cooper | Conditions: Delayed Graft Function | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-04-26